Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q1 2014 · 10-Q
Revenue$5.32M$5.32M+15.7% vs Q1 2013 Net Income$397.11K$397.11K+62.7% vs Q1 2013 EPS Diluted$0.04$0.04+100.0% vs Q1 2013 Operating Income$804,525+42.9% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Free Cash Flowderived-$117,721N/M Margins · derivedOperating margin15.1%+2.9 pt vs Q1 2013
Net margin7.5%+2.2 pt vs Q1 2013
ended Feb 28, 2014 · filed Apr 14, 2014 · 45 d after period end